Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $482000.0.

  • Biomerica's Cash from Financing Activities changed N/A to $482000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $3.1 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2025, which is 270617.28% up from last year.
  • Per Biomerica's latest filing, its Cash from Financing Activities stood at $482000.0 for Q4 2025.
  • Over the past 5 years, Biomerica's Cash from Financing Activities peaked at $7.4 million during Q2 2023, and registered a low of -$5000.0 during Q2 2025.
  • Over the past 4 years, Biomerica's median Cash from Financing Activities value was $721173.5 (recorded in 2021), while the average stood at $1.1 million.
  • In the last 5 years, Biomerica's Cash from Financing Activities tumbled by 9994.09% in 2021 and then surged by 1941413.78% in 2023.
  • Quarter analysis of 4 years shows Biomerica's Cash from Financing Activities stood at $913988.0 in 2021, then crashed by 74.07% to $237000.0 in 2022, then soared by 3001.27% to $7.4 million in 2023, then crashed by 93.44% to $482000.0 in 2025.
  • Its Cash from Financing Activities stands at $482000.0 for Q4 2025, versus $920000.0 for Q3 2025 and -$5000.0 for Q2 2025.